(Q42785972)

7 November 2017

0 references

Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?). (English)

1 reference

7 November 2017

author name string

Vincenzo Stanghellini

series ordinal

1

1 reference

7 November 2017

Chiara Frisoni

series ordinal

2

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

The American Journal of Gastroenterology

7 November 2017

published in

1 reference

7 November 2017

volume

105

1 reference

7 November 2017

issue

12

1 reference

7 November 2017

page(s)

2632-2634

1 reference

The functional gastrointestinal disorders and the Rome III process

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Unmet medical needs among patients with gastroesophageal reflux disease: a foundation for improving management in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Prokinetics and fundic relaxants in upper functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

Predominant symptoms identify different subgroups in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.354

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.354

1 reference

Dimensions Publication ID

7 November 2017

1033025849

0 references

1 reference